Sunday, September 6, 2026

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

Kim Ju-ae, First Visit To Kumsusan Palace Where Predecessors’ Bodies Lie… Kim Jong-un·Ri Sol-ju

Kim Jong Un visited the Kumsusan Palace on New Year's Day, honoring predecessors and encouraging young performers for the future.

South Korea Plans to Replace 75% of Frontline Troops with AI-Driven Surveillance

South Korea plans to cut frontline troops from 22,000 to 6,000 using AI, amid concerns over North Korean military drills.

Tag: Osong

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Celltrion Expands PFS Production Capacity to 70 Million: What This Means for the Global Market

Celltrion Pharmaceutical plans to invest 2 trillion KRW to expand its pre-filled syringe production capacity to meet global demand.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.